Page last updated: 2024-10-21

pk 11195 and Lupus Erythematosus, Systemic

pk 11195 has been researched along with Lupus Erythematosus, Systemic in 1 studies

PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pugliese, F1
Gaemperli, O1
Kinderlerer, AR1
Lamare, F1
Shalhoub, J1
Davies, AH1
Rimoldi, OE1
Mason, JC1
Camici, PG1

Other Studies

1 other study available for pk 11195 and Lupus Erythematosus, Systemic

ArticleYear
Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography.
    Journal of the American College of Cardiology, 2010, Aug-17, Volume: 56, Issue:8

    Topics: Adult; Aged; Angiography; Arteries; Carbon Radioisotopes; Female; Giant Cell Arteritis; Humans; Imag

2010